Global RNA Biopesticide Market Growth (Status and Outlook) 2026-2032

October 2026 | 96 pages | ID: G37A9FB44D3AEN
LP Information

Abstracts

The global RNA Biopesticide market size is predicted to grow from US$ 92.05 million in 2025 to US$ 355 million in 2032; it is expected to grow at a CAGR of 19.4% from 2026 to 2032.

RNA Biopesticide refers to crop-protection products and pesticidal traits whose biological activity is primarily based on RNA molecules, particularly double-stranded RNA (dsRNA), which induce RNA interference (RNAi) and sequence-specific gene silencing in target pests or pathogens. The market is primarily divided into PIP and Non-PIP pathways. PIP products are plant-incorporated protectants in which genetically engineered crops express pesticidal RNA within plant tissues and are commercialized mainly through seed and trait systems. Non-PIP products use externally manufactured RNA active ingredients that are formulated for foliar spray, irrigation, root-zone application, seed treatment, or other targeted delivery routes. Core technical elements include target-sequence design, RNA production and purification, formulation, delivery, environmental stabilization, target uptake, and quality control. By Application, the market is divided into Farmland, Orchard, and Other applications, covering major field crops, potatoes, fruit crops, tobacco, protected horticulture, and other specialty crops.

Key Findings

PIP remains the dominant commercial pathway, supported mainly by established RNAi traits in major field crops

Non-PIP is emerging as the principal incremental growth direction as externally applied RNA products broaden their crop and target coverage

Farmland remains the primary commercial application, while orchard and specialty-crop applications are moving toward broader commercialization

Commercial maturity remains highly uneven by region, with established markets coexisting with regulatory-entry and pre-commercial regions

The competitive landscape is concentrated in realized revenue but substantially broader in technology development and product pipelines

Market Trends

The RNA Biopesticide industry is transitioning from a market led primarily by RNAi-based PIP traits toward a more diversified structure in which externally applied Non-PIP products play an increasingly important role. Commercial PIP technologies remain concentrated in major field crops, especially corn, while Non-PIP development is expanding into insect control, fungal disease management, plant-virus control, nematodes, and other targeted applications. Advances in biological and cell-free RNA manufacturing, formulation stability, encapsulation, controlled release, uptake enhancement, and environmental protection are improving the practical feasibility of externally applied RNA products. Product development is also moving from narrowly defined crop-pest combinations toward broader portfolios covering potatoes, grapes, tobacco, horticultural crops, and other high-value applications. The long-term direction is toward highly selective crop-protection tools that can be integrated with conventional chemical and biological products in integrated pest management and resistance-management programs.

Market Dynamics

Drivers

Market development is being driven by increasing resistance to established pesticide modes of action, growing demand for selective crop-protection solutions, stricter residue and environmental expectations, and continued advances in RNA manufacturing and delivery technologies. Commercial deployment of RNAi traits has demonstrated the feasibility of RNA-based crop protection at agricultural scale, while the emergence of registered externally applied products is establishing an additional commercialization pathway. Regulatory progress in major agricultural markets and increasing participation by established seed and crop-protection companies are also supporting the transition from research-oriented development toward broader commercial adoption.

Restraints

Commercialization remains constrained by formulation stability and field-performance limitations, particularly RNA degradation caused by ultraviolet exposure, rainfall, temperature, and biological activity in the environment. For Non-PIP products, manufacturing cost, application rate, delivery efficiency, and cost per hectare remain important commercial considerations. PIP products depend on genetically engineered seed and trait systems, making adoption closely linked to biotechnology regulation and seed-market acceptance. The still-limited number of registered RNA products and relatively narrow crop-target combinations also restrict near-term market breadth.

Opportunities

The most significant market opportunities are expected to come from the expansion of Non-PIP products into applications that are difficult to address through seed-based PIP systems. Potential growth areas include fungal diseases, plant viruses, difficult-to-control insect pests, nematodes, high-value fruit crops, protected horticulture, and specialty crops. Orchard and vineyard systems are particularly attractive because of high crop value, intensive crop-protection requirements, and strong demand for selective and low-residue solutions. Additional opportunities are also emerging in regions where regulatory pathways are becoming clearer and local field-validation programs are progressing toward registration and commercialization.

Challenges

The industry must demonstrate consistent field efficacy across different crops, climates, application systems, and pest populations while maintaining economically competitive treatment costs. Developers also face lengthy regulatory processes, extensive environmental and non-target testing requirements, scale-up risks in RNA manufacturing, formulation complexity, and the need to establish effective technical-support and distribution systems. Long-term commercialization will also depend on resistance-management stewardship, accurate target selection, intellectual-property protection, manufacturing reliability, and coordination among technology developers, seed companies, crop-protection companies, regulators, distributors, and growers.

Industry Chain Analysis

The RNA Biopesticide industry chain differs significantly between PIP and Non-PIP products. For PIP, upstream activities include target discovery, gene-sequence selection, genetic construct development, crop transformation, breeding, trait integration, seed multiplication, and regulatory testing. For Non-PIP, the upstream chain is more manufacturing-intensive and includes RNA sequence design, biological or cell-free synthesis, purification, analytical testing, formulation carriers, adjuvants, encapsulation materials, stabilizers, and delivery technologies. Technical value is increasingly concentrated in low-cost RNA production, environmental stability, target uptake, and effective delivery under field conditions.

Midstream activities include trait commercialization and seed production for PIP products, and RNA active-ingredient manufacturing, formulation, filling, packaging, and quality assurance for Non-PIP products. Downstream participants include seed and trait companies, crop-protection formulators, agricultural distributors, retailers, professional application services, grower cooperatives, and commercial growers. PIP economics are mainly linked to the value attributable to the RNAi pesticidal trait within a commercial seed system, while Non-PIP profitability depends more directly on RNA production cost, dose per hectare, formulation cost, manufacturing utilization, registered crop coverage, and channel efficiency. As the industry matures, value creation is expected to shift increasingly toward proprietary sequence design, formulation and delivery technologies, regulatory assets, and commercially validated crop-target portfolios.

Segment Insights

PIP remains the dominant product pathway because of established commercialization in major field crops, mature seed-distribution systems, and the scalability of trait-based deployment. However, its relative dominance is expected to moderate as Non-PIP products expand into additional crops, pests, and diseases. Non-PIP has stronger structural flexibility because externally applied RNA products can be adapted to multiple crops and target organisms without relying on genetically engineered seed systems. Improvements in RNA production economics, formulation stability, and delivery efficiency are expected to strengthen its commercial relevance over time.

By Application, Farmland remains the principal commercial segment, supported by RNAi traits in field crops and the commercialization of externally applied RNA products in selected broadacre applications. Orchard applications are developing around high-value fruit crops, fungal disease control, and other targeted uses where selective and low-residue solutions are particularly attractive. Other applications include tobacco, greenhouse and protected horticulture, nurseries, flowers, and specialty crops, where controlled production environments and high crop value can support adoption of targeted Non-PIP technologies.

Downstream Market Opportunities

Downstream demand is expected to broaden from large-scale field-crop production toward higher-value and more specialized crop-protection systems. Field crops will remain the principal commercial foundation because of established RNAi traits and extensive planted areas, while potatoes and other crops facing insecticide-resistance pressure provide opportunities for externally applied RNA insecticides. Orchards, vineyards, protected horticulture, tobacco, vegetables, and other specialty crops offer attractive opportunities where growers place greater value on residue management, target specificity, and novel modes of action. The strongest commercial opportunities are likely to emerge where RNA products can be integrated into existing application practices and provide clear resistance-management, efficacy, or residue advantages.

Regional Insights

Regional commercialization remains highly uneven. North America and Latin America currently represent the principal commercial markets, supported largely by established RNAi crop traits, while North America also has the most diversified commercialization structure because both PIP and externally applied Non-PIP products have entered agricultural use. Latin America remains strongly supported by large-scale field-crop production and PIP adoption, while externally applied RNA products are creating additional development opportunities in high-value and export-oriented crops.

Europe remains at an early commercialization and regulatory-expansion stage, with Non-PIP products expected to play a leading role in future adoption. China has entered initial commercialization and is developing capabilities in RNA manufacturing, formulation, and domestic product development. Asia-Pacific excluding China remains mainly in R&D and pre-commercial development, with Australia and Japan important in technology development and other Asian agricultural markets providing longer-term application potential. The Middle East and Africa remain earlier-stage markets, with potential concentrated in high-value horticulture, protected agriculture, and other specialized crop-protection applications.

Competitive Landscape Analysis

The RNA Biopesticide market is highly concentrated in realized commercial revenue but considerably more diverse in technology development and product pipelines. Bayer has a strong commercial position in PIP through established RNAi corn traits, while Corteva is expanding its presence through next-generation corn trait systems. GreenLight Biosciences represents one of the most advanced commercial participants in externally applied Non-PIP RNA biopesticides. Other companies, including RNAissance Ag, Pebble Labs, Renaissance BioScience, AgroSpheres, Silicon Gene, Shanghai Plant Science Biotechnology, and Xiaomo Biotech, are positioned across RNA manufacturing, microbial or yeast-based delivery, formulation platforms, field-stage products, registration programs, and early commercialization. Competitive differentiation is increasingly shifting from ownership of individual RNAi traits toward integrated capabilities in low-cost RNA manufacturing, formulation and delivery, regulatory execution, target-specific product development, manufacturing scale-up, and access to seed or crop-protection distribution channels.

Report Scope

LPI (LP Information)' newest research report, the “RNA Biopesticide Industry Forecast” looks at past sales and reviews total world RNA Biopesticide sales in 2025, providing a comprehensive analysis by region and market sector of projected RNA Biopesticide sales for 2026 through 2032. With RNA Biopesticide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RNA Biopesticide industry.

This Insight Report provides a comprehensive analysis of the global RNA Biopesticide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on RNA Biopesticide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global RNA Biopesticide market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RNA Biopesticide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RNA Biopesticide.

This report presents a comprehensive overview, market shares, and growth opportunities of RNA Biopesticide market by product type, application, key players and key regions and countries.

Market Segmentation

Segmentation by Type:

• PIP
• Non-PIP

Segmentation by Target Organism:

• Insect Pests
• Nematodes and Mites
• Pathogens
• Other

Segmentation by Crop:

• Potatoes
• Corn
• Other

Segmentation by Application:

• Farmland
• Orchard
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Bayer
• Corteva
• GreenLight Biosciences
• RNAissance Ag
• Pebble Labs
• Renaissance BioScience
• AgroSpheres
• Silicon Gene
• Shanghai Plant Science Biotechnology
• Xiaomo Biotech

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global RNA Biopesticide Market Size (2021-2032)
  2.1.2 RNA Biopesticide Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for RNA Biopesticide by Country/Region (2021, 2025 & 2032)
2.2 RNA Biopesticide Segment by Type
  2.2.1 PIP
  2.2.2 Non-PIP
  2.2.3 RNA Biopesticide Market Size by Type
    2.2.3.1 RNA Biopesticide Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.3.2 Global RNA Biopesticide Market Size Market Share by Type (2021-2026)
2.3 RNA Biopesticide Segment by Target Organism
  2.3.1 Insect Pests
  2.3.2 Nematodes and Mites
  2.3.3 Pathogens
  2.3.4 Other
  2.3.5 RNA Biopesticide Market Size by Target Organism
    2.3.5.1 RNA Biopesticide Market Size CAGR by Target Organism (2021 VS 2025 VS 2032)
    2.3.5.2 Global RNA Biopesticide Market Size Market Share by Target Organism (2021-2026)
2.4 RNA Biopesticide Segment by Crop
  2.4.1 Potatoes
  2.4.2 Corn
  2.4.3 Other
  2.4.4 RNA Biopesticide Market Size by Crop
    2.4.4.1 RNA Biopesticide Market Size CAGR by Crop (2021 VS 2025 VS 2032)
    2.4.4.2 Global RNA Biopesticide Market Size Market Share by Crop (2021-2026)
2.5 RNA Biopesticide Segment by Application
  2.5.1 Farmland
  2.5.2 Orchard
  2.5.3 Other
  2.5.4 RNA Biopesticide Market Size by Application
    2.5.4.1 RNA Biopesticide Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.5.4.2 Global RNA Biopesticide Market Size Market Share by Application (2021-2026)

3 RNA BIOPESTICIDE MARKET SIZE BY PLAYER

3.1 RNA Biopesticide Market Size Market Share by Player
  3.1.1 Global RNA Biopesticide Revenue by Player (2021-2026)
  3.1.2 Global RNA Biopesticide Revenue Market Share by Player (2021-2026)
3.2 Global RNA Biopesticide Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RNA BIOPESTICIDE BY REGION

4.1 RNA Biopesticide Market Size by Region (2021-2026)
4.2 Global RNA Biopesticide Annual Revenue by Country/Region (2021-2026)
4.3 Americas RNA Biopesticide Market Size Growth (2021-2026)
4.4 APAC RNA Biopesticide Market Size Growth (2021-2026)
4.5 Europe RNA Biopesticide Market Size Growth (2021-2026)
4.6 Middle East & Africa RNA Biopesticide Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas RNA Biopesticide Market Size by Country (2021-2026)
5.2 Americas RNA Biopesticide Market Size by Type (2021-2026)
5.3 Americas RNA Biopesticide Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC RNA Biopesticide Market Size by Region (2021-2026)
6.2 APAC RNA Biopesticide Market Size by Type (2021-2026)
6.3 APAC RNA Biopesticide Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe RNA Biopesticide Market Size by Country (2021-2026)
7.2 Europe RNA Biopesticide Market Size by Type (2021-2026)
7.3 Europe RNA Biopesticide Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa RNA Biopesticide by Region (2021-2026)
8.2 Middle East & Africa RNA Biopesticide Market Size by Type (2021-2026)
8.3 Middle East & Africa RNA Biopesticide Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RNA BIOPESTICIDE MARKET FORECAST

10.1 Global RNA Biopesticide Forecast by Region (2027-2032)
  10.1.1 Global RNA Biopesticide Forecast by Region (2027-2032)
  10.1.2 Americas RNA Biopesticide Forecast
  10.1.3 APAC RNA Biopesticide Forecast
  10.1.4 Europe RNA Biopesticide Forecast
  10.1.5 Middle East & Africa RNA Biopesticide Forecast
10.2 Americas RNA Biopesticide Forecast by Country (2027-2032)
  10.2.1 United States Market RNA Biopesticide Forecast
  10.2.2 Canada Market RNA Biopesticide Forecast
  10.2.3 Mexico Market RNA Biopesticide Forecast
  10.2.4 Brazil Market RNA Biopesticide Forecast
10.3 APAC RNA Biopesticide Forecast by Region (2027-2032)
  10.3.1 China RNA Biopesticide Market Forecast
  10.3.2 Japan Market RNA Biopesticide Forecast
  10.3.3 Korea Market RNA Biopesticide Forecast
  10.3.4 Southeast Asia Market RNA Biopesticide Forecast
  10.3.5 India Market RNA Biopesticide Forecast
  10.3.6 Australia Market RNA Biopesticide Forecast
10.4 Europe RNA Biopesticide Forecast by Country (2027-2032)
  10.4.1 Germany Market RNA Biopesticide Forecast
  10.4.2 France Market RNA Biopesticide Forecast
  10.4.3 UK Market RNA Biopesticide Forecast
  10.4.4 Italy Market RNA Biopesticide Forecast
  10.4.5 Russia Market RNA Biopesticide Forecast
10.5 Middle East & Africa RNA Biopesticide Forecast by Region (2027-2032)
  10.5.1 Egypt Market RNA Biopesticide Forecast
  10.5.2 South Africa Market RNA Biopesticide Forecast
  10.5.3 Israel Market RNA Biopesticide Forecast
  10.5.4 Turkey Market RNA Biopesticide Forecast
10.6 Global RNA Biopesticide Forecast by Type (2027-2032)
10.7 Global RNA Biopesticide Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market RNA Biopesticide Forecast

11 KEY PLAYERS ANALYSIS

11.1 Bayer
  11.1.1 Bayer Company Information
  11.1.2 Bayer RNA Biopesticide Product Offered
  11.1.3 Bayer RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Bayer Main Business Overview
  11.1.5 Bayer Latest Developments
11.2 Corteva
  11.2.1 Corteva Company Information
  11.2.2 Corteva RNA Biopesticide Product Offered
  11.2.3 Corteva RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Corteva Main Business Overview
  11.2.5 Corteva Latest Developments
11.3 GreenLight Biosciences
  11.3.1 GreenLight Biosciences Company Information
  11.3.2 GreenLight Biosciences RNA Biopesticide Product Offered
  11.3.3 GreenLight Biosciences RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 GreenLight Biosciences Main Business Overview
  11.3.5 GreenLight Biosciences Latest Developments
11.4 RNAissance Ag
  11.4.1 RNAissance Ag Company Information
  11.4.2 RNAissance Ag RNA Biopesticide Product Offered
  11.4.3 RNAissance Ag RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 RNAissance Ag Main Business Overview
  11.4.5 RNAissance Ag Latest Developments
11.5 Pebble Labs
  11.5.1 Pebble Labs Company Information
  11.5.2 Pebble Labs RNA Biopesticide Product Offered
  11.5.3 Pebble Labs RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Pebble Labs Main Business Overview
  11.5.5 Pebble Labs Latest Developments
11.6 Renaissance BioScience
  11.6.1 Renaissance BioScience Company Information
  11.6.2 Renaissance BioScience RNA Biopesticide Product Offered
  11.6.3 Renaissance BioScience RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Renaissance BioScience Main Business Overview
  11.6.5 Renaissance BioScience Latest Developments
11.7 AgroSpheres
  11.7.1 AgroSpheres Company Information
  11.7.2 AgroSpheres RNA Biopesticide Product Offered
  11.7.3 AgroSpheres RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 AgroSpheres Main Business Overview
  11.7.5 AgroSpheres Latest Developments
11.8 Silicon Gene
  11.8.1 Silicon Gene Company Information
  11.8.2 Silicon Gene RNA Biopesticide Product Offered
  11.8.3 Silicon Gene RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Silicon Gene Main Business Overview
  11.8.5 Silicon Gene Latest Developments
11.9 Shanghai Plant Science Biotechnology
  11.9.1 Shanghai Plant Science Biotechnology Company Information
  11.9.2 Shanghai Plant Science Biotechnology RNA Biopesticide Product Offered
  11.9.3 Shanghai Plant Science Biotechnology RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Shanghai Plant Science Biotechnology Main Business Overview
  11.9.5 Shanghai Plant Science Biotechnology Latest Developments
11.10 Xiaomo Biotech
  11.10.1 Xiaomo Biotech Company Information
  11.10.2 Xiaomo Biotech RNA Biopesticide Product Offered
  11.10.3 Xiaomo Biotech RNA Biopesticide Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Xiaomo Biotech Main Business Overview
  11.10.5 Xiaomo Biotech Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. RNA Biopesticide Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. RNA Biopesticide Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of PIP
Table 4. Major Players of Non-PIP
Table 5. RNA Biopesticide Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global RNA Biopesticide Market Size by Type (2021-2026) & ($ millions)
Table 7. Global RNA Biopesticide Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Insect Pests
Table 9. Major Players of Nematodes and Mites
Table 10. Major Players of Pathogens
Table 11. Major Players of Other
Table 12. RNA Biopesticide Market Size CAGR by Target Organism (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global RNA Biopesticide Market Size by Target Organism (2021-2026) & ($ millions)
Table 14. Global RNA Biopesticide Market Size Market Share by Target Organism (2021-2026)
Table 15. Major Players of Potatoes
Table 16. Major Players of Corn
Table 17. Major Players of Other
Table 18. RNA Biopesticide Market Size CAGR by Crop (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global RNA Biopesticide Market Size by Crop (2021-2026) & ($ millions)
Table 20. Global RNA Biopesticide Market Size Market Share by Crop (2021-2026)
Table 21. RNA Biopesticide Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global RNA Biopesticide Market Size by Application (2021-2026) & ($ millions)
Table 23. Global RNA Biopesticide Market Size Market Share by Application (2021-2026)
Table 24. Global RNA Biopesticide Revenue by Player (2021-2026) & ($ millions)
Table 25. Global RNA Biopesticide Revenue Market Share by Player (2021-2026)
Table 26. RNA Biopesticide Key Players Head office and Products Offered
Table 27. RNA Biopesticide Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global RNA Biopesticide Market Size by Region (2021-2026) & ($ millions)
Table 31. Global RNA Biopesticide Market Size Market Share by Region (2021-2026)
Table 32. Global RNA Biopesticide Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global RNA Biopesticide Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas RNA Biopesticide Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas RNA Biopesticide Market Size Market Share by Country (2021-2026)
Table 36. Americas RNA Biopesticide Market Size by Type (2021-2026) & ($ millions)
Table 37. Americas RNA Biopesticide Market Size Market Share by Type (2021-2026)
Table 38. Americas RNA Biopesticide Market Size by Application (2021-2026) & ($ millions)
Table 39. Americas RNA Biopesticide Market Size Market Share by Application (2021-2026)
Table 40. APAC RNA Biopesticide Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC RNA Biopesticide Market Size Market Share by Region (2021-2026)
Table 42. APAC RNA Biopesticide Market Size by Type (2021-2026) & ($ millions)
Table 43. APAC RNA Biopesticide Market Size by Application (2021-2026) & ($ millions)
Table 44. Europe RNA Biopesticide Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe RNA Biopesticide Market Size Market Share by Country (2021-2026)
Table 46. Europe RNA Biopesticide Market Size by Type (2021-2026) & ($ millions)
Table 47. Europe RNA Biopesticide Market Size by Application (2021-2026) & ($ millions)
Table 48. Middle East & Africa RNA Biopesticide Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa RNA Biopesticide Market Size by Type (2021-2026) & ($ millions)
Table 50. Middle East & Africa RNA Biopesticide Market Size by Application (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of RNA Biopesticide
Table 52. Key Market Challenges & Risks of RNA Biopesticide
Table 53. Key Industry Trends of RNA Biopesticide
Table 54. Global RNA Biopesticide Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global RNA Biopesticide Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global RNA Biopesticide Market Size Forecast by Type (2027-2032) & ($ millions)
Table 57. Global RNA Biopesticide Market Size Forecast by Application (2027-2032) & ($ millions)
Table 58. Bayer Details, Company Type, RNA Biopesticide Area Served and Its Competitors
Table 59. Bayer RNA Biopesticide Product Offered
Table 60. Bayer RNA Biopesticide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Bayer Main Business
Table 62. Bayer Latest Developments
Table 63. Corteva Details, Company Type, RNA Biopesticide Area Served and Its Competitors
Table 64. Corteva RNA Biopesticide Product Offered
Table 65. Corteva RNA Biopesticide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Corteva Main Business
Table 67. Corteva Latest Developments
Table 68. GreenLight Biosciences Details, Company Type, RNA Biopesticide Area Served and Its Competitors
Table 69. GreenLight Biosciences RNA Biopesticide Product Offered
Table 70. GreenLight Biosciences RNA Biopesticide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. GreenLight Biosciences Main Business
Table 72. GreenLight Biosciences Latest Developments
Table 73. RNAissance Ag Details, Company Type, RNA Biopesticide Area Served and Its Competitors
Table 74. RNAissance Ag RNA Biopesticide Product Offered
Table 75. RNAissance Ag RNA Biopesticide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. RNAissance Ag Main Business
Table 77. RNAissance Ag Latest Developments
Table 78. Pebble Labs Details, Company Type, RNA Biopesticide Area Served and Its Competitors
Table 79. Pebble Labs RNA Biopesticide Product Offered
Table 80. Pebble Labs RNA Biopesticide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Pebble Labs Main Business
Table 82. Pebble Labs Latest Developments
Table 83. Renaissance BioScience Details, Company Type, RNA Biopesticide Area Served and Its Competitors
Table 84. Renaissance BioScience RNA Biopesticide Product Offered
Table 85. Renaissance BioScience RNA Biopesticide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Renaissance BioScience Main Business
Table 87. Renaissance BioScience Latest Developments
Table 88. AgroSpheres Details, Company Type, RNA Biopesticide Area Served and Its Competitors
Table 89. AgroSpheres RNA Biopesticide Product Offered
Table 90. AgroSpheres RNA Biopesticide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. AgroSpheres Main Business
Table 92. AgroSpheres Latest Developments
Table 93. Silicon Gene Details, Company Type, RNA Biopesticide Area Served and Its Competitors
Table 94. Silicon Gene RNA Biopesticide Product Offered
Table 95. Silicon Gene RNA Biopesticide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Silicon Gene Main Business
Table 97. Silicon Gene Latest Developments
Table 98. Shanghai Plant Science Biotechnology Details, Company Type, RNA Biopesticide Area Served and Its Competitors
Table 99. Shanghai Plant Science Biotechnology RNA Biopesticide Product Offered
Table 100. Shanghai Plant Science Biotechnology RNA Biopesticide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Shanghai Plant Science Biotechnology Main Business
Table 102. Shanghai Plant Science Biotechnology Latest Developments
Table 103. Xiaomo Biotech Details, Company Type, RNA Biopesticide Area Served and Its Competitors
Table 104. Xiaomo Biotech RNA Biopesticide Product Offered
Table 105. Xiaomo Biotech RNA Biopesticide Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Xiaomo Biotech Main Business
Table 107. Xiaomo Biotech Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. RNA Biopesticide Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global RNA Biopesticide Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. RNA Biopesticide Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. RNA Biopesticide Sales Market Share by Country/Region (2025)
Figure 8. RNA Biopesticide Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global RNA Biopesticide Market Size Market Share by Type in 2025
Figure 10. Global RNA Biopesticide Market Size Market Share by Target Organism in 2025
Figure 11. Global RNA Biopesticide Market Size Market Share by Crop in 2025
Figure 12. RNA Biopesticide in Farmland
Figure 13. Global RNA Biopesticide Market: Farmland (2021-2026) & ($ millions)
Figure 14. RNA Biopesticide in Orchard
Figure 15. Global RNA Biopesticide Market: Orchard (2021-2026) & ($ millions)
Figure 16. RNA Biopesticide in Other
Figure 17. Global RNA Biopesticide Market: Other (2021-2026) & ($ millions)
Figure 18. Global RNA Biopesticide Market Size Market Share by Application in 2025
Figure 19. Global RNA Biopesticide Revenue Market Share by Player in 2025
Figure 20. Global RNA Biopesticide Market Size Market Share by Region (2021-2026)
Figure 21. Americas RNA Biopesticide Market Size 2021-2026 ($ millions)
Figure 22. APAC RNA Biopesticide Market Size 2021-2026 ($ millions)
Figure 23. Europe RNA Biopesticide Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa RNA Biopesticide Market Size 2021-2026 ($ millions)
Figure 25. Americas RNA Biopesticide Value Market Share by Country in 2025
Figure 26. United States RNA Biopesticide Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada RNA Biopesticide Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico RNA Biopesticide Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil RNA Biopesticide Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC RNA Biopesticide Market Size Market Share by Region in 2025
Figure 31. APAC RNA Biopesticide Market Size Market Share by Type (2021-2026)
Figure 32. APAC RNA Biopesticide Market Size Market Share by Application (2021-2026)
Figure 33. China RNA Biopesticide Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan RNA Biopesticide Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea RNA Biopesticide Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia RNA Biopesticide Market Size Growth 2021-2026 ($ millions)
Figure 37. India RNA Biopesticide Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia RNA Biopesticide Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe RNA Biopesticide Market Size Market Share by Country in 2025
Figure 40. Europe RNA Biopesticide Market Size Market Share by Type (2021-2026)
Figure 41. Europe RNA Biopesticide Market Size Market Share by Application (2021-2026)
Figure 42. Germany RNA Biopesticide Market Size Growth 2021-2026 ($ millions)
Figure 43. France RNA Biopesticide Market Size Growth 2021-2026 ($ millions)
Figure 44. UK RNA Biopesticide Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy RNA Biopesticide Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia RNA Biopesticide Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa RNA Biopesticide Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa RNA Biopesticide Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa RNA Biopesticide Market Size Market Share by Application (2021-2026)
Figure 50. Egypt RNA Biopesticide Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa RNA Biopesticide Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel RNA Biopesticide Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey RNA Biopesticide Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries RNA Biopesticide Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 56. APAC RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 57. Europe RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 59. United States RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 60. Canada RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 61. Mexico RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 62. Brazil RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 63. China RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 64. Japan RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 65. Korea RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 67. India RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 68. Australia RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 69. Germany RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 70. France RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 71. UK RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 72. Italy RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 73. Russia RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 74. Egypt RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 75. South Africa RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 76. Israel RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 77. Turkey RNA Biopesticide Market Size 2027-2032 ($ millions)
Figure 78. Global RNA Biopesticide Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global RNA Biopesticide Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries RNA Biopesticide Market Size 2027-2032 ($ millions)